Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Nucleic Acids Research|July 31, 2004
Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGHMarine Guillaud-Bataille, Alexander Valent, Pascal Soularue, et al.The American Journal of Pathology|February 13, 2002
DeltaN-p73alpha accumulates in human neuroblastic tumorsSétha Douc-Rasy, Michel Barrois, Maria Echeynne, et al.The Journal of Clinical Investigation|February 18, 2010
Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosisJimena Bouzas-Rodriguez, Jorge Ruben Cabrera, Céline Delloye-Bourgeois, et al.Cancer Genetics and Cytogenetics|August 25, 2004
Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumorsAlexander Valent, Marine Guillaud-Bataille, Chantal Farra, et al.Glycobiology|December 4, 2016
Revisiting the human polypeptide GalNAc-T1 and T13 paralogsMaría Florencia Festari, Felipe Trajtenberg, Nora Berois, et al.Journal of the National Cancer Institute|October 15, 2014
Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastomaBenjamin Gibert, Céline Delloye-Bourgeois, Charles-Henry Gattolliat, et al.Cancer|August 27, 2004
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplificationAnne Laprie, Jean Michon, Olivier Hartmann, et al.Molecular Oncology|April 23, 2009
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4SJean Bénard, Gilda Raguénez, Audrey Kauffmann, et al.European Journal of Human Genetics : EJHG|November 11, 2011
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndromeFranck Bourdeaut, Sandrine Ferrand, Laurence Brugières, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Prognostic impact of gene expression-based classification for neuroblastomaAndré Oberthuer, Barbara Hero, Frank Berthold, et al.Pageof 6